(1.02%) 5 099.96 points
(0.40%) 38 240 points
(2.03%) 15 928 points
(0.11%) $83.66
(-1.16%) $1.619
(0.30%) $2 349.60
(-0.47%) $27.23
(0.41%) $924.25
(0.32%) $0.935
(0.80%) $11.04
(0.16%) $0.801
(-0.32%) $91.87
Live Chart Being Loaded With Signals
Lonza Group Ltd supplies products and services to the pharmaceutical, biotech, and nutrition markets in Switzerland and internationally. It operates through Biologics, Small Molecules, Cell and Gene, and Capsules and Health Ingredients divisions...
Stats | |
---|---|
Today's Volume | 141 876 |
Average Volume | 220 196 |
Market Cap | 39.21B |
EPS | CHF0 ( 2024-01-25 ) |
Next earnings date | ( CHF0 ) 2024-07-19 |
Last Dividend | CHF0 ( N/A ) |
Next Dividend | CHF0 ( N/A ) |
P/E | 34.72 |
ATR14 | CHF0.245 (0.05%) |
Volume Correlation
Lonza Group AG Correlation
10 Most Positive Correlations |
---|
10 Most Negative Correlations |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Lonza Group AG Correlation - Currency/Commodity
Lonza Group AG Financials
Annual | 2023 |
Revenue: | CHF6.72B |
Gross Profit: | CHF1.82B (27.04 %) |
EPS: | CHF8.88 |
FY | 2023 |
Revenue: | CHF6.72B |
Gross Profit: | CHF1.82B (27.04 %) |
EPS: | CHF8.88 |
FY | 2022 |
Revenue: | CHF6.22B |
Gross Profit: | CHF2.30B (36.96 %) |
EPS: | CHF16.37 |
FY | 2021 |
Revenue: | CHF5.41B |
Gross Profit: | CHF2.11B (39.01 %) |
EPS: | CHF39.65 |
Financial Reports:
No articles found.
Lonza Group AG
Lonza Group Ltd supplies products and services to the pharmaceutical, biotech, and nutrition markets in Switzerland and internationally. It operates through Biologics, Small Molecules, Cell and Gene, and Capsules and Health Ingredients divisions. The Biologics division engages in the contract development and manufacturing services for biopharmaceuticals. The Small Molecules division operates as an integrated development and manufacturing service provider for small molecule drug substances and their intermediates. The Cell and Gene division develops technologies and platforms that industrialize the manufacturing processes and production of cell and gene therapies. It also offers contract development and manufacturing services for a range of allogeneic and autologous cell therapies, and exosome-based therapies, as well as viral vector gene therapies. This segment provides specialty raw materials and enabling technology solutions in cell and gene therapy, injectable drugs, vaccines, and bio-manufacturing markets. The Capsules and Health Ingredients division offers capsules, dosage form solutions, and health ingredients for pharmaceutical and nutraceutical customers. Lonza Group Ltd was founded in 1897 and is headquartered in Basel, Switzerland.
About Live Signals
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.
The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators